Migraine and Patent Foramen Ovale (PFO)

Patent Foramen Ovale: Diagnosis and Treatment

Patent Foramen Ovale: Diagnosis and Treatment Anthony DeMaria Judy and Jack White Chair in Cardiology University of California, San Diego At one time or another a Grantee, Sponsored Speaker or Ad-hoc Consultant

PERCUTANEOUS CLOSURE OF PATENT FORAMEN OVALE AND ATRIAL SEPTAL DEFECT: STATE OF THE ART AND A CRITICAL APPRAISAL

PERCUTANEOUS CLOSURE OF PATENT FORAMEN OVALE AND ATRIAL SEPTAL DEFECT: STATE OF THE ART AND A CRITICAL APPRAISAL Carmelo Cernigliaro Clinica San Gaudenzio Novara Eco 2D e 3D Eco Transesofageo Large shunt

Why Should We Treat PFO?

Why Should We Treat PFO? SCAI Interventional Cardiology Fellows Course December 7, 2012 Jonathan Tobis, MD Director of Interventional Cardiology UCLA Disclosures Jonathan Tobis, MD 1. A Principal Investigator

PFO Closure is a Therapy for Migraine PRO

PFO Closure is a Therapy for Migraine PRO Andrew Charles, M.D. Professor Director, UCLA Goldberg Migraine Program Meyer and Renee Luskin Chair in Migraine and Headache Studies Director, Headache Research

Devices for Stroke Prevention. Douglas Ebersole, MD Interventional Cardiology Watson Clinic LLP

Devices for Stroke Prevention Douglas Ebersole, MD Interventional Cardiology Watson Clinic LLP Overview Left Atrial Appendage Closure FDA Approved Watchman Investigational Amulet PFO Closure Atrial Fibrillation

PFO Closure for the Management of Migraine and Stroke

PFO Closure for the Management of Migraine and Stroke Sun U. Kwon Department of Neurology, Asan Medical Center, UUMC Contents PFO & Migraine PFO causes Migraine or Not? PFO closure for Migraine PFO & Stroke

Antithrombotic Summit Basel 2012 Basel, 26. April Peter T. Buser Klinik Kardiologie Unviersitätsspital Basel

Antithrombotic Summit Basel 2012 Basel, 26. April 2012 Peter T. Buser Klinik Kardiologie Unviersitätsspital Basel Background stroke = third-leading cause of death among adults 1/5 of stroke survivors require

The Patent Foramen Ovale A Preventable Stroke Etiology?! Brian Whisenant, M.D.

The Patent Foramen Ovale A Preventable Stroke Etiology?! Brian Whisenant, M.D. Conflict of Interest Statement I have a financial interest in Coherex Medical. Heart Disease and Stroke Statistics 2008 Update:

Why Treat Patent Forman Ovale

Why Treat Patent Forman Ovale Clifford J Kavinsky, MD, PHD Professor of Medicine and pediatrics Associate Director, Center for Congenital and Structural Heart Disease Rush University Medical Center Conclusions

PFO- To Close for Comfort. By: Vincent J.Caracciolo, MD FACC

PFO- To Close for Comfort By: Vincent J.Caracciolo, MD FACC PATENT FORAMEN OVALE PFO- congenital lesion that frequently persists into adulthood ( 25-30%)- autopsy and TEE studies. PFO prevalence higher

Cryptogenic Stroke: What Don t We Know. Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare

Cryptogenic Stroke: What Don t We Know Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare Financial Disclosures None Objectives Principles of diagnostic evaluation

PFO (Patent Foramen Ovale): Smoking Gun or an Innocent Bystander?

PFO (Patent Foramen Ovale): Smoking Gun or an Innocent Bystander? J Thompson Sullebarger, M.D. Florida Cardiovascular Institute University of South Florida Kris Letang Tedy Bruschi Bret Michaels The Atrial

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS 11-8-18 Outline 1. Background 2. Anatomy of patent foramen ovale (PFO) 3. Relationship between PFO and

Benign Headache and Diagnosis Pathophysiology. Dr Andrew J Dowson Director of the King s Headache Service King s College Hospital London

Benign Headache and Diagnosis Pathophysiology Dr Andrew J Dowson Director of the King s Headache Service King s College Hospital London Case histories Case 1 Male, 46 y - Truck driver - Headaches since

I, (Issam Moussa) DO NOT have a financial interest/arrangement t/ t or affiliation with one or more organizations that could be perceived as a real

PFO Closure: Where We Are Going to after CLOSURE I Study? Issam D. Moussa, MD Professor of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, Florida Disclosure Statement of

DEBATE: PFO MANAGEMENT TO CLOSE OR NOT TO CLOSE. Matthew Starr, MD Stroke Attending

DEBATE: PFO MANAGEMENT TO CLOSE OR NOT TO CLOSE Matthew Starr, MD Stroke Attending DISCLOSURES None DEBATE Should PFO be closed? * * Sometimes yes THE CASE AGAINST PFO CLOSURE 1. Did the PFO cause the

GERIATRICS CASE PRESENTATION

GERIATRICS CASE PRESENTATION CASE 79 year old Patient X was admitted to hospital with SOB. He had a hx of sarcoidosis and asbestosis. Home oxygen requirement is 3-3.5litre. He was admitted, given ceftriaxone

Fabien Praz, Andreas Wahl, Sophie Beney, Stephan Windecker, Heinrich P. Mattle*, Bernhard Meier

Procedural Outcome after Percutaneous Closure of Patent Foramen Ovale using the Amplatzer PFO Occluder Without Intra-Procedural Echocardiography in 1,000 Patients Fabien Praz, Andreas Wahl, Sophie Beney,

PFO Management update

PFO Management update May 12, 2017 Peter Casterella, MD Swedish Heart and Vascular 1 PFO Update 2017: Objectives Review recently released late outcomes of RESPECT trial and subsequent FDA approval of PFO

2017 Cardiovascular Symposium CRYPTOGENIC STROKE: A CARDIOVASCULAR PERSPECTIVE DR. WILLIAM DIXON AND DR. VENKATA BAVAKATI SOUTHERN MEDICAL GROUP, P.A.

CRYPTOGENIC STROKE: 2017 Cardiovascular Symposium A CARDIOVASCULAR PERSPECTIVE DR. WILLIAM DIXON AND DR. VENKATA BAVAKATI SOUTHERN MEDICAL GROUP, P.A. CRYPTOGENIC STROKE CRYPTOGENIC: OF OBSCURE OR UNKNOWN

Description. Page: 1 of 23. Closure Devices for Patent Foramen Ovale and Atrial Septal Defects. Last Review Status/Date: December 2014

Last Review Status/Date: December 2014 Page: 1 of 23 Description Background Patent Foramen Ovale The foramen ovale, a component of fetal cardiovascular circulation, consists of a communication between

Perspectives on PFO Closure: Clinical Trials for Stroke Prevention and Migraines

Perspectives on PFO Closure: Clinical Trials for Stroke Prevention and Migraines Mark Reisman,, MD Swedish Heart and Vascular Institute Seattle, Wa Disclosure National PI for the MIST trial- No financial

The Relation of Migraine Headaches and Interatrial Shunts

PFO AND MIGRAINE HOSPITAL CHRONICLES 2006, SUPPLEMENT: 73 78 CARDIOLOGY UPDATE 2006 The Relation of Migraine Headaches and Interatrial Shunts Konstantinos G. Kappos, MD, Vassiliki Tsagou, MD, George Andrikopoulos,

Percutaneous closure of a patent foramen ovale after cryptogenic stroke

Neth Heart J (2018) 26:5 12 https://doi.org/10.1007/s12471-017-1063-3 POINT OF VIEW Percutaneous closure of a patent foramen ovale after cryptogenic stroke R. J. R. Snijder 1 M.J.Suttorp 1 J.M.tenBerg

Cryptogenic Stroke and Migraine Headache: The Clinical Cardiologist s View

CRYPTOGENIC STROKE, MIGRAINE & PFO HOSPITAL CHRONICLES 2006, SUPPLEMENT: 67 72 CARDIOLOGY UPDATE 2006 Cryptogenic Stroke and Migraine Headache: The Clinical Cardiologist s View Harold L. Kennedy, MD A

HEADACHE & FACIAL PAIN SECTION

Pain Medicine 2014; 15: 2156 2160 Wiley Periodicals, Inc. HEADACHE & FACIAL PAIN SECTION Original Research Article An Association Between Migraines and Heart Anomalies True or False? A Heart Ultrasound

Echocardiography Conference

Echocardiography Conference David Stultz, MD Cardiology Fellow, PGY-6 September 20, 2005 Atrial Septal Aneurysm Bulging of Fossa Ovalis Associated commonly with Atrial septal defect or small perforations

Transcatheter Closure of Septal Defects

Transcatheter Closure of Septal Defects Policy Number: 2.02.09 Last Review: 11/2018 Origination: 3/2007 Next Review: 11/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

Current management aspects in adult congenital heart disease: non-surgical closure of patent foramen ovale

Review Article Current management aspects in adult congenital heart disease: non-surgical closure of patent foramen ovale Kaivan Vaidya 1,2, Chinmay Khandkar 1,2, David Celermajer 1,2 1 Department of Cardiology,

Stroke and ASA / FO REBUTTAL

REBUTTAL Definition of an ischemic stroke Definition of a PFO Evidence for a causal role of PFO in stroke Evidence against a role of PFO in stroke Stroke recurrencies in stroke (PFO) patients Medical treatment

JACC: CARDIOVASCULAR INTERVENTIONS VOL. 3, NO. 3, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin

JACC: CARDIOVASCULAR INTERVENTIONS VOL. 3, NO. 3, 2010 2010 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/10/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2009.11.019 Primary

PFO closure group total no. PFO closure group no. of males

Suppl Table. Characteristics of the five trials included in this meta-analysis. Trial name Device used for Definition of medical Primary Endpoint group total no. group no. of males group age (yrs) group

Patent foramen ovale (PFO) is composed of

PFO Closure for Prevention of Recurrent Cryptogenic Stroke The evidence base is here. BY JOHN F. RHODES, JR, MD Patent foramen ovale (PFO) is composed of overlapping portions of septum primum and septum

Clinical Commissioning Policy Statement: Patent Foramen Ovale (PFO) Closure. April Reference: NHSCB/A09/PS/a

Clinical Commissioning Policy Statement: Patent Foramen Ovale (PFO) Closure April 2013 Reference: NHSCB/A09/PS/a NHS Commissioning Board Clinical Commissioning Policy Statement: Patent Foramen Ovale (PFO)

Cryptogenic Stroke: A logical approach to a common clinical problem

Cryptogenic Stroke: A logical approach to a common clinical problem Alphonse M. Ambrosia, DO, FACC Interventional Cardiologist CardioVascular Associates of Mesa Mesa, Arizona Speakers Bureau Boston Scientific

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of percutaneous closure of patent foramen ovale for the secondary prevention

Disclosure. Consultation: Rimed, Philips Healthcare Research: Philips Healthcare

Zsolt Garami, MD Transcranial Doppler Bubble Test for PFO (Does the saline solution or body position matter?) Methodist DeBakey Heart and Vascular Center, The Methodist Hospital Research Institute, The

Transcatheter Closure of Septal Defects

Transcatheter Closure of Septal Defects Policy Number: 2.02.09 Last Review: 11/2017 Origination: 3/2007 Next Review: 11/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

Transcatheter closure of patent foramen ovale using the internal jugular venous approach

New methods in diagnosis and therapy Transcatheter closure of patent foramen ovale using the internal jugular venous approach Przemysław Węglarz 1,2, Ewa Konarska-Kuszewska 2, Tadeusz Zębik 2, Piotr Kuszewski

RESPECT Safety Findings

CO-1 SCAI Town Hall Meeting Monday, October 31, 2016 Washington, DC RESPECT Safety Findings John D. Carroll, M.D., MSCAI Professor of Medicine Cardiology University of Colorado School of Medicine University

PFO CLOSURE: WHAT S NEW?

PFO CLOSURE: WHAT S NEW? 1. AHA rescinds major sections of 2018 AHA/ASA Stroke Guidelines 2. PFO closure is cost effective 3. Now 12 meta-analyses of PFO/Stoke RCT confirm PFO closure superiority 4. FDA

A 29-Year-Old Man With Acute Onset Blurry Vision, Weakness, and Gait Abnormality

Clinical Case of the Month A 29-Year-Old Man With Acute Onset Blurry Vision, Weakness, and Gait Abnormality Deepu Thoppil, MD; Murtuza J. Ali, MD; Neeraj Jain, MD; Sanjay Kamboj, MD; Pramilla Subramaniam,

CLOSE. Closure of Patent Foramen Ovale, Oral anticoagulants or Antiplatelet Therapy to Prevent Stroke Recurrence

CLOSE Closure of Patent Foramen Ovale, Oral anticoagulants or Antiplatelet Therapy to Prevent Stroke Recurrence Guillaume TURC, MD, PhD Paris Descartes University Sainte-Anne hospital Paris, France On

PATENT FORAMEN OVALE: UPDATE IN MANAGEMENT OF RECURRENT STROKE KATRINE ZHIROFF, MD, FACC, FSCAI LOS ANGELES CARDIOLOGY ASSOCIATES

PATENT FORAMEN OVALE: UPDATE IN MANAGEMENT OF RECURRENT STROKE KATRINE ZHIROFF, MD, FACC, FSCAI LOS ANGELES CARDIOLOGY ASSOCIATES OBJECTIVES Review social burden and epidemiology of stroke Gender disparities

Effect of Having a PFO Occlusion Device in Place in the RESPECT PFO Closure Trial

Effect of Having a PFO Occlusion Device in Place in the RESPECT PFO Closure Trial DAVID E. THALER, MD, PHD, JEFFREY L. SAVER, MD RICHARD W. SMALLING, MD, PHD, JOHN D. CARROLL, MD, SCOTT BERRY, PHD, LEE

Comorbidities of migraine

Comorbidities of migraine Jasna Zidverc Trajković Headache center Comorbidity is greater than coincidental association of two (or more) conditions in the same individual. Feinstein 1963 Migraine has been

Management and Investigation of Ischemic Stroke By Etiology

Management and Investigation of Ischemic Stroke By Etiology Andrew M. Demchuk MD FRCPC Director, Calgary Stroke Program Deputy Dept Head, Clinical Neurosciences Heart and Stroke Foundation Chair in Stroke

Small- and Moderate-Size Right-to-Left Shunts Identified by Saline Contrast Echocardiography Are Normal and Unrelated to Migraine Headache

CHEST Original Research Small- and Moderate-Size Right-to-Left Shunts Identified by Saline Contrast Echocardiography Are Normal and Unrelated to Migraine Headache Timothy D. Woods, MD, FCCP; Leanne Harmann,

ΣΥΓΚΛΕΙΣΗ ΑΝΟΙΚΤΟΥ ΩΟΕΙΔΟΥΣ ΤΡΗΜΑΤΟΣ ΠΕΣΡΟ. ΔΑΡΔΑ, MD, FESC 33 Ο Πανελλήνιο Καρδιολογικό Συνζδριο ΑΘΗΝΑ 2012

ΣΥΓΚΛΕΙΣΗ ΑΝΟΙΚΤΟΥ ΩΟΕΙΔΟΥΣ ΤΡΗΜΑΤΟΣ 2012 ΠΕΣΡΟ. ΔΑΡΔΑ, MD, FESC 33 Ο Πανελλήνιο Καρδιολογικό Συνζδριο ΑΘΗΝΑ 2012 The Problem: Not All PFO in Patients With Cryptogenic Stroke is Pathogenic; No Definitive

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know S. Andrew Josephson, MD Director, Neurohospitalist Program Medical Director, Inpatient Neurology University

Patent foramen ovale morphology and stroke size

Priority Paper evaluation Patent foramen ovale morphology and stroke size Evaluation of: Akhondi A, Gevorgyan R, Tseng CH et al.: The Association of patent foramen ovale morphology and stroke size in patients

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index Note: Page numbers of article titles are in boldface type. A Acute ischemic stroke TOAST classification of, 270 Acute myocardial infarction (AMI) cardioembolic stroke following, 207 208 noncardioembolic

BASIL D. THANOPOULOS MD, PhD Associate Professor Honorary Consultant, RBH, London, UK

TRANSCATHETER CLOSURE OF ATRIAL SEPTAL DEFECT AND PFO BASIL D. THANOPOULOS MD, PhD Associate Professor Honorary Consultant, RBH, London, UK TRANSCATHETER CLOSURE OF ATRIAL SEPTAL DEFECT AND PFO BASIL D.

Migraine, a recurrent headache disorder of children and adults, significantly affects quality of life and results in a substantial

Patent Foramen Ovale in Children with Migraine Headaches Rachel T. McCandless, MD, Cammon B. Arrington, MD, Douglas C. Nielsen, James F. Bale, Jr., MD, and L. LuAnn Minich, MD Objective To determine the

CPAG Summary Report for Clinical Panel Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke

MANAGEMENT IN CONFIDENCE CPAG Summary Report for Clinical Panel Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke The Benefits of the Proposition Percutaneous Patent Foramen Ovale

The influence of percutaneous atrial septal defect closure on the occurrence of migraine

European Heart Journal (2005) 26, 1533 1537 doi:10.1093/eurheartj/ehi170 Clinical research The influence of percutaneous atrial septal defect closure on the occurrence of migraine Katrin Mortelmans 1,

Rahul Jhaveri, M.D. The Heart Group of Lancaster General Health

Rahul Jhaveri, M.D. The Heart Group of Lancaster General Health INTRODUCTION Three recently published randomized controlled trials in The New England Journal of Medicine provide new information about closure

AVC Criptogénico: Está na altura de alterar as guidelines? Claudia Jorge University Hospital of Santa Maria

Está na altura de alterar as guidelines? Claudia Jorge University Hospital of Santa Maria Está na altura de alterar as guidelines? Está na altura de alterar as guidelines? ~25% of all ischemic strokes

Original Article Improving migraine by means of primary transcatheter patent foramen ovale closure: long-term follow-up

Am J Cardiovasc Dis 2012;2(2):89-95 www.ajcd.us /ISSN:2160-200X/AJCD1201001 Original Article Improving migraine by means of primary transcatheter patent foramen ovale closure: long-term follow-up Gianluca

Cryptogenic Stroke/PFO with Thrombophilia and VTE: Do We Know What To Do?

Cryptogenic Stroke/PFO with Thrombophilia and VTE: Do We Know What To Do? Robert J. Sommer, MD Columbia University Medical Center New York, NY Disclosure Statement of Financial Interest Within the past

Patent Foramen Ovale Its Correlation with Other Maladies and a Review of Detection Screening

Patent Foramen Ovale Its Correlation with Other Maladies and a Review of Detection Screening Michael W Jopling, MD 1, John A Kurowski, BS, RN 2 and Suzanne M Williams, MS 2 1. Chief Medical Officer, Cardiox

2D/3D in Evaluation of Atrial Septum

2D/3D in Evaluation of Atrial Septum Roberto M Lang, MD OSTIUM SECUNDUM ASD: 2D AND 3D TNSESOPHAGEAL ECHO 1 Biplane views 90 0 3D Acquisi on Acquire 3D volume Lang RM et al. JASE 2012;25:3 46. Right atrial

Update interventional Cardiology Hans Rickli St.Gallen

Update interventional Cardiology 2012 Hans Rickli St.Gallen 26.11.2012 Review of Literature ESC-Highlights TCT/AHA-Highlights Update interventional cardiology 2012 Structural Heart Disease Transcatheter

FORAME OVALE PERVIO E ICTUS CRIPTOGENETICO: Dimensione del problema. Roberto Mantovan, MD, PhD U.O. Cardiologia Ospedale M.

FORAME OVALE PERVIO E ICTUS CRIPTOGENETICO: Dimensione del problema Roberto Mantovan, MD, PhD U.O. Cardiologia Ospedale M. Bufalini - Cesena FORAME OVALE PERVIO ICTUS CRIPTOGENETICO FORAME OVALE PERVIO

PRACTICAL NEUROLOGY. An endovascular device to close a patent foramen ovale: b. Patent foram Blackwell Publishing Ltd

4 PRACTICAL NEUROLOGY Patent foram An endovascular device to close a patent foramen ovale: b FEBRUARY 2003 5 Jean-Louis Mas Service de Neurologie, Hôpital Sainte-Anne, 1 rue Cabanis, 75674 Paris Cedex

T here is an association between migraine with aura and

1315 CONGENITAL HEART DISEASE Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura P T Wilmshurst, M J Pearson, S Nightingale, K P Walsh, W

INSTRUCTIONS FOR USE FOR:

INSTRUCTIONS FOR USE FOR: en English bg INSTRUCTIONS FOR USE FOR: GORE CARDIOFORM SEPTAL OCCLUDER Carefully read all instructions prior to use. Observe all warnings and precautions noted throughout these

Requesting Adult Transthoracic Echocardiograms with Bubble Study

Requesting Adult Transthoracic Echocardiograms with Bubble Study Type: Clinical Guideline Register No: 11050 Status: Public Developed in response to: Contributes to CQC Core Outcome The need to prevent

Advanced Emboli Monitoring: PFO and Stroke & PFO and Migraine EMBOLI. Emboli. Alex Razumovsky, PhD, FAHA Director Sentient NeuroCare Services, Inc.

Advanced Emboli Monitoring: PFO and Stroke & PFO and Migraine Alex Razumovsky, PhD, FAHA Director Sentient NeuroCare Services, Inc. Neurovascular Ultrasound Course Wake Forest University School of Medicine

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,500 108,000 1.7 M Open access books available International authors and editors Downloads Our

Supplementary webappendix

Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Hart RG, Diener H-C, Coutts SB, et al,

Imaging. Lack of Association Between Migraine Headache and Patent Foramen Ovale Results of a Case-Control Study

Imaging Lack of Association Between Migraine Headache and Patent Foramen Ovale Results of a Case-Control Study Pallav Garg, MBBS, MSc; Stephen J. Servoss, MD, MSc; Justina C. Wu, MD, PhD; Zahid H. Bajwa,

Echocardiography in Systemic Embolization. January 29, 2007 Joe M. Moody, Jr, MD UTHSCSA and STVHCS

Echocardiography in Systemic Embolization January 29, 2007 Joe M. Moody, Jr, MD UTHSCSA and STVHCS Neurologic Events and Cardiac Source of Embolus For patients who present with evidence of abrupt arterial

Migraine is a common neurological disorder and has been

Patent Foramen Ovale With Atrial Septal Aneurysm Is Strongly Associated With Migraine With Aura: A Large Observational Study Roel J. R. Snijder, MD; Justin G. L. M. Luermans, MD, PhD; Albert H. de Heij,

TRANSCATHETER CLOSURE OF ATRIAL SEPTAL DEFECT AND PFO

TRANSCATHETER CLOSURE OF ATRIAL SEPTAL DEFECT AND PFO BASIL D. THANOPOULOS MD, PhD Associate Professor Agios Loukas Clinic, Thessaloniki, Greece Ares Heart Center, Bucharest, Romania Honorary Consultant,

Patent Foramen Ovale Closure Using a Bioabsorbable Closure Device

JACC: CARDIOVASCULAR INTERVENTIONS VOL. 3, NO. 9, 2010 2010 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2010.06.012 Patent Foramen

Foam Sclerotherapy and Patent Foramen Ovale (PFO) Gillet J-L J L (France)

Foam Sclerotherapy and Patent Foramen Ovale (PFO) Gillet J-L J L (France) Abano Terme, October 2013 1 Definition PFO is an incomplete closure of the atrial septum that results in the creation of a flap

Even though it was first proposed as a cause of stroke in

Is Patent Foramen Ovale a Modifiable Risk Factor for Stroke Recurrence? David M. Kent, MD, MS; David E. Thaler, MD, PhD Abstract Although the prevalence of a patent foramen ovale (PFO) in the general population

It has been 133 years since the German anatomist J.

PFO Closure to Prevent Recurrent TIA and Stroke What is the evidence base for patent foramen ovale closure? BY MICHAEL H. SALINGER, MD, FACC, FSCAI; MEHMET CILINGIROGLU, MD, FACC, FESC, FSCAI; JUSTIN P.

Valvular Heart Disease and Adult Congenital Intervention. A Pichard, MD. Director Cath Labs, Washington Hospital Center. Georgetown University.

Valvular Heart Disease and Adult Congenital Intervention. A Pichard, MD Director Cath Labs, Washington Hospital Center. ProfessorofMedicine (Cardiology), Georgetown University. Conflict of Interest Proctor

Γεώργιος Δ. Κατσιμαγκλής. Αν. Διευθυντής Καρδιολογικής ΚλινικήςΝΝΑ Διευθυντής Αιμοδυναμικού Εργαστηρίου ΝΝΑ

Γεώργιος Δ. Κατσιμαγκλής Αν. Διευθυντής Καρδιολογικής ΚλινικήςΝΝΑ Διευθυντής Αιμοδυναμικού Εργαστηρίου ΝΝΑ I have no disclosures ΣΥΧΝΟΤΗΤΑ An atrial septal defect (ASD) is a deficiency of the atrial septum.

Medical Policy Surgical Treatment of Migraine Headache

Medical Policy Surgical Treatment of Migraine Headache Effective Date: January, 2011; Revised [7/13; 7/15] Subject: Surgical Treatment of Migraine Headache Overview: Several surgical treatments are being

Patent Foramen Ovale Closure Without Echocardiographic Control: Use of Standby Intracardiac Ultrasound

JACC: CARDIOVASCULAR INTERVENTIONS VOL. 1, NO. 4, 2008 2008 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/08/$34.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2008.05.006 Patent Foramen

Patent Foramen Ovale May Be Causal for the First Stroke but Unrelated to Subsequent Ischemic Events

Patent Foramen Ovale May Be Causal for the First Stroke but Unrelated to Subsequent Ischemic Events Marie-Luise Mono, MD; Laura Geister, BSc; Aekaterini Galimanis, MD; Simon Jung, MD; Fabien Praz, MD;

Paradoxical Air Microembolism Induces Cerebral Bioelectrical Abnormalities and Occasionally Headache in Patent Foramen Ovale Patients With Migraine

Paradoxical Air Microembolism Induces Cerebral Bioelectrical Abnormalities and Occasionally Headache in Patent Foramen Ovale Patients With Migraine Eser Basßak Sevgi, MD; Sefik Evren Erdener, MD; Mehmet

Atrial Septal Defect Closure. Stephen Brecker Director, Cardiac Catheterisation Labs

Stephen Brecker Director, Cardiac Catheterisation Labs ADVANCED ANGIOPLASTY Incorporating The Left Main 5 Plus Course Conflicts of Interest The following companies have supported educational courses held

11/27/2017 DISCLOSURE CRYPTOGENIC STROKE CLINICAL PATHWAYS. No Relevant Financial Disclosures Sub-Investigator LEARNING OBJECTIVES

CRYPTOGENIC STROKE CLINICAL PATHWAYS Michelle Lee Kearney, ACNP-BC NP, Stroke Program St Thomas Health Nashville, TN DISCLOSURE No Relevant Financial Disclosures Sub-Investigator Stroke-AF Trial (Medtronic)

2018 Update in Diagnosis and Management of Stroke

2018 Update in Diagnosis and Management of Stroke S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Chair, Department of Neurology Director,

Stroke in patients with migraine

Stroke in patients with migraine Jacques De Reuck 1, Koen Paemeleire 1, Georges Van Maele 2 1Department of Neurology, Ghent University Hospital, Ghent, Belgium 2Biostatistical Unit, Ghent University Hospital,

Clinical Policy: Transcatheter Closure of Patent Foramen Ovale Reference Number: CP.MP.151

Clinical Policy: Reference Number: CP.MP.151 Effective Date: 12/17 Last Review Date: 12/17 See Important Reminder at the end of this policy for important regulatory and legal information. Coding Implications

Stroke is the third leading cause of death in the United

Cryptogenic Stroke in Patients with Patent Foramen Ovale Carlos E. Sanchez, MD, Joo A. Lee, MD, Geoffrey Eubank, MD, and Steven J. Yakubov, MD Abstract Objective: To discuss what is known regarding patent

Transcatheter Closure of Cardiovascular Defects

Medical Coverage Policy Effective Date...11/15/2017 Next Review Date...11/15/2018 Coverage Policy Number... 0011 Transcatheter Closure of Cardiovascular Defects Table of Contents Related Coverage Resources

CLINICAL FEATURES THAT SUPPORT ATHEROSCLEROTIC STROKE 1. cerebral cortical impairment (aphasia, neglect, restricted motor involvement, etc.) or brain stem or cerebellar dysfunction 2. lacunar clinical

Modern aspects in multidisciplinary thromboembolic prophylaxis. AMPLATZER Left Atrial Appendage data update

Modern aspects in multidisciplinary thromboembolic prophylaxis AMPLATZER Left Atrial Appendage data update Igal Moarof, MD Interventional Cardiology Kantonsspital Aarau Potential conflicts of interest

True cryptogenic stroke

True cryptogenic stroke Arne Lindgren, MD, PhD Dept of Clinical Sciences Lund, Neurology, Lund University Dept of Neurology and Rehabilitation Medicine Skåne University Hospital Lund, Sweden Disclosures

Intracardiac echocardiography: an ideal guiding tool for device closure of interatrial communications

Eur J Echocardiography (2005) 6, 92e96 Intracardiac echocardiography: an ideal guiding tool for device closure of interatrial communications Thomas Bartel a, *, Thomas Konorza a, Ulrich Neudorf b, Tiko

Left Atrial Appendage Closure: Neurological events

Left Atrial Appendage Closure: Neurological events Medical Director- Foundation for Cardiovascular Medicine San Diego, CA Director Advanced Interventional Therapies- Gagnon Cardiovascular Institute, Morristown,

Does Transcatheter Closure of Patent Foramen Ovale Really Shut the Door? A Prospective Study With Transcranial Doppler

Does Transcatheter Closure of Patent Foramen Ovale Really Shut the Door? A Prospective Study With Transcranial Doppler G.P. Anzola, MD; E. Morandi, MD; F. Casilli, MD; E. Onorato, MD, FSCAI Background

Permanent Right-to-Left Shunt Is the Key Factor in Managing Patent Foramen Ovale

Journal of the American College of Cardiology Vol. 58, No. 21, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.06.064